Atividade mutagênica de plantas medicinais

The number of studies of genotoxic activity of medicinal plants has been growing alongside with their increasing therapeutic use and scientific interest in proving their effectiveness for a variety of pharmacological purposes. This reflects the fact that many of the plants used by great numbers of people, in spite of their proven pharmacological value, can also cause harmful changes in the DNA. The risks are greater when alternative treatments are applied in an uncontrolled way, without due attention to correct botanical identification, to the part of the plant that should to be used and to the method of preparation and administration. In this review, aspects of the mutagenic activity of some medicinal plants are discussed.

Comportamento do implante contendo bone morphogenetic protein (bmp) associado ao plasma rico em plaquetas na reparação de fraturas orbitárias

Purpose: This study intends to evaluate BMP (Bone Morphogenetic Protein) implant and BMP implant plus PRP (Platelet Rich Plasma) in rabbit orbital fractures, searching for tissue reaction, by radiological and morfometrical analysis. Methods:Third six white rabbits were submitted to orbital floor fracture and distributed in three groups: G1, with rabbits receiving a plate containing decalcified bone matrix and BMP; G2, with rabbits receiving the implant with BMP wrapped by PRP; G3, the control group where it was made the fracture only. The animals were evaluated radiologically after surgery and at sacrifice time in 7, 30, 90 and 180th day after surgery. After sacrifice, a block containing the right orbital tissue was extracted and prepared to morphological and morphometrical analysis. Results: An intensive linfomononuclear inflammatory reaction was observed at 7th day in G1 e G2, witch decreased after the 30th day; mesenchimal cells, osteoblasts, new bone and progressive cavitation of the implant were also observed, besides signs of calcium deposition by radiological study. In the control group fibrosis at the site of fracture was identified only. Conclusion: BMP seemed a good orbital implant producing new bone at the implant site and correcting bone defect.There was not observed acceleration of osteoinduction when the implant was associated with PRP.

Insulinoterapia, controle glicêmico materno e prognóstico perinatal - Diferença entre o diabetes gestacional e o clínico

PURPOSE: to evaluate the insulin therapy protocol and its maternal and perinatal outcome in patients with clinical or gestational diabetes in a high risk reference service. METHODS: descriptive and prospective study including 103 pregnant women with gestational or clinical diabetes treated with insulin and attended by the reference service from October 2003 to December 2005. Gemellarity, miscarriages, unfinished prenatal care and deliveries not attended by the service were excluded. The gestational age at the beginning of the treatment, dosage, doses/day, increment of insulin (UI/kg), glycemic index (GI) and perinatal outcomes were compared. ANOVA, Fisher's exact test and Goodman's test considering p<0.05 were used. RESULTS: multiparity (92 versus 67.9%), pre-gestational body mass index (BMI) >25 kg/m 2 (88 versus 58.5%), weight gain (WG) <8 kg (36 versus 17%) and a high increment of insulin characterized the gestational diabetes. For the patients with clinical diabetes, despite the highest GI (120 mg/dL (39.2 versus 24%)) at the end of the gestational period, insulin therapy started earlier (47.2 versus 4%), lasted longer (56.6 versus 6%) and higher doses of insulin (92 versus 43 UI/day) were administered up to three times a day (54.7 versus 16%). Macrosomia was higher among newborns from the cohort of patients with gestational diabetes (16 versus 3.8%), being the only significant neonatal outcome. There were no neonatal deaths, except for one fetal death in the cohort of patients with clinical diabetes. There were no differences in the other neonatal complications in both cohorts, and most of the newborns were discharged from hospital up to seven days after delivery (46% versus 55.8%). CONCLUSIONS: the analysis of these two cohorts has shown differences in the insulin therapy protocol in quantity (UI/day), dosage (UI/kg weight) and number of doses/day, higher for the clinical diabetes cohort, and in the increment of insulin, higher for the gestational diabetes cohort. Indirectly, the quality of maternal glycemic control and the satisfactory perinatal outcome have proven that the treatment protocol was adequate and did not depend on the type of diabetes.

Efeito do raloxifeno sobre a densidade mamográfica em mulheres na pós-menopausa

PURPOSE: to evaluate changes in mammographic breast density in postmenopausal women using raloxifene. METHODS: in this clinical trial, 80 women (mean age=61.1 years) were studied prospectively. Forty patients received 60 mg/day raloxifene, and 40 women comprised the non-treated group (control), paired by age and time of menopause. The treated group was composed of patients with osteoporosis of the lumbar spine. Those with history of breast surgery and users of hormone therapy up to six months prior to the study were excluded. The breast density was assessed qualitatively (subjective) and quantitatively (objective) in two moments, initial and final, after a 6-month follow-up. The 320 mammograms (craniocaudal and oblique) were interpreted qualitatively by the Breast Imaging Reporting and Data System (BI-RADS) classification and quantitatively by digital scanning and computer-assisted segmentation. For statistical analysis t-test, Wilcoxon Mann-Whitney, Spearman correlation and the kappa index were used. RESULTS: on the initial statistical comparison, the groups were considered homogenous for the variables: analyzed age, time of menopause, parity, breast feeding, previous hormonal therapy and body mass index. Baseline breast density, by qualitative and quantitative methods, correlated negatively with the age in both groups (p<0.05). Concerning the other variables, there was no correlation. After six months, no alteration was observed in the mammographic breast density in 38 women of raloxifene group and 38 of the control group, by qualitative method. However, by quantitative method, no alteration was observed in 30 women of the raloxifene group and 27 controls (p>0.05). It was observed a weak agreement rate (kappa=0.25) between the BI-RADS classification and digital scanning/computer-assisted segmentation. CONCLUSIONS: in post-menopausal women with osteoporosis, submitted to raloxifene treatment for six months, no alterations were observed on the mammographic breast density.

Investigação do potencial genotóxico do extrato de Garcinia achachairu in vivo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Estudo da eficiência da água ozonizada como solução irrigadora na eliminação de Candida albicans, Enterococcus faecalis e endotoxinas do canal radicular

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Avaliação do óleo essencial de Citrus aurantium e do seu constituinte majoritário, limoneno, como adjuvantes no tratamento da artrite reumatóide em ratos com úlceras gástricas

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Efeitos do uso de retinóide sintético no coração de adolescentes e jovens em tratamento de acne

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Formação de biofilmes e resistência a antifúngico e biocidas em Candida parapsilosis e C. orthopsilosis isoladas de águas usadas para hemodiálise

Pós-graduação em Biociências e Biotecnologia Aplicadas à Farmácia - FCFAR

A influência da utilização de plantas medicinais nos custos do tratamento de agravos atendidos pela assistência farmacêutica básica

O uso de plantas medicinais para tratamento dos males da saúde está disseminado não só nas áreas rurais como também nas áreas urbanas do território brasileiro. O significado econômico destas plantas medicinais, usadas no atendimento das necessidades básicas de saúde, para as economias domésticas da parte socialmente vulnerável da população, ainda é pouco investigado. Muitas espécies vegetais são comercializadas na cidade de Belém por erveiros em mercados ou feiras livres da cidade. Este trabalho tem como objetivo analisar em que medida a inserção do uso de Plantas Medicinais minimiza os custos do tratamento de agravos atendidos pela Assistência Farmacêutica na Atenção Básica á saúde para o usuário do Sistema de Saúde. Para se atingir esse objetivo, foi realizado um estudo, de natureza exploratória, por meio de aplicação de questionários, utilizando o método de amostragem, definida por critério não probabilístico, no bairro do Jurunas com apoio na Unidade de Saúde Radional II, localizado na Região Metropolitana de Belém no Pará. Foi realizado um levantamento de informações referente ao foco deste estudo no Centro de Referência de Tratamento Natural (CRTN), localizado na cidade de Macapá, que já utiliza as plantas medicinais como recurso terapêutico. No resultado da pesquisa de campo no bairro do Jurunas foi verificado que aproximadamente 50% dos entrevistados praticam a automedicação com plantas medicinais, relacionadas na RDC nº 10/ANVISA, sendo necessária, entretanto, orientação correta para seu cultivo e emprego terapêutico. A comparação entre os gastos com medicamentos sintéticos no tratamento dos sintomas de cinco doenças que ocorrem com frequência no bairro do Jurunas e aqueles resultantes do uso de plantas medicinais, para os mesmos sintomas, revela uma redução no gasto para tratamentos feitos à base de plantas medicinais. Em conclusão, pode-se inferir que esta redução representa uma economia de recursos que o usuário e o sistema deixam de despender quando utilizam plantas medicinais.

Estudo longitudinal da terapia antibiótica local de bolsas periodontais residuais. Análise clínica e microbiológica

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Avaliação do plasma rico em plaquetas no tratamento de defeitos ósseos e lesões periodontais de furca grau II. Estudos histológico e histomorfométrico em cães

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Efeito dos óleos essenciais de Syzygium aromaticum e Cinnamomum zeylanicume e seus compostos majoritários na produçao de biofilme em cepas de Staphylococcus aureus, isolados de leite de vacas com mastite subclínica

Pós-graduação em Biologia Geral e Aplicada - IBB

Investigação das atividades alelopática, fitotóxica e antioxidante de extratos e frações de Tridax procumbens L. (Asteraceae). e Ouratea spectabilis (mart. ex engl.) engl. (Ochnaceae)

Pós-graduação em Biociências - FCLAS

Atividade in vivo de parasporina extraída de B. thuringiensis sobre o câncer colorretal murino (CT‐26)

Bacillus thuringiensis (Bt), is an environmental Gram-positive spore-forming bacterium that produces crystalline parasporal protein (Cry) during sporulation. The inclusions often exhibit strong and specific insecticidal activity, making Bt an agent for agricultural controlling insects pest, mites, protozoa and nematodes. Recent studies reported that some of these Crys do not show cytotoxicity against insects but they are capable to kill some human and animal cancer cells. These proteins were denominated parasporins (PS). However, antitumor activity of Bt parasporin on the development of murine colorectal cancer (CT-26), are not well studies and these are no reports on the in vivo effect of these proteins. Thus, the present study evaluated the in vitro and in vivo anti-tumoral activity of Bt parasporin against the murine colorectal cancer line CT-26. Therefore, Balb/c mice were s.c. inoculated with CT-26 cells and weekly treated with parasporin (i.p.) pre-activated by enzymatic digestion with trypsin or proteinase K. Our results have shown, for the first time, that despite the anti-tumor activity in vitro, parasporin crystals couldn’t combat tumor growth in vivo. Instead, this protein was highly toxic, affecting the liver and spleen, with possible effect on other organs, decreasing the survival of treated animals. The results indicate the need for studies to better detoxification or manipulation of parasporin for therapeutic use and new studies for analysis of toxicological effects of repetitive exposure of farmers to this toxin